Silo Pharma Files 8-K: Regulation FD Disclosure & Other Events
Ticker: SILO · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1514183
| Field | Detail |
|---|---|
| Company | Silo Pharma, Inc. (SILO) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory
TL;DR
Silo Pharma (SILO) filed an 8-K on 3/10/25 covering Reg FD and other events.
AI Summary
On March 10, 2025, Silo Pharma, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The company, formerly known as Uppercut Brands, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. The filing also includes financial statements and exhibits.
Why It Matters
This 8-K filing provides important updates and disclosures from Silo Pharma, Inc. to the public, ensuring transparency regarding company events and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for disclosures and does not indicate immediate financial distress or significant operational changes.
Key Numbers
- 001-41512 — SEC File Number (Identifies the company's filing with the SEC.)
- 27-3046338 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Silo Pharma, Inc. (company) — Registrant
- Uppercut Brands, Inc. (company) — Former Company Name
- March 10, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- Sarasota, FL (location) — Principal Executive Address
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What are the 'Other Events' mentioned in the filing?
The filing lists 'Other Events' as an item information, but the specific nature of these events is not detailed in the provided text.
When was Silo Pharma, Inc. formerly known as Uppercut Brands, Inc.?
The date of the name change from Uppercut Brands, Inc. to Silo Pharma, Inc. was August 8, 2019.
What is Silo Pharma, Inc.'s primary business sector?
Silo Pharma, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
Where is Silo Pharma, Inc. headquartered?
Silo Pharma, Inc.'s principal executive address is 677 N. Washington Boulevard, Sarasota, FL 34236.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Silo Pharma, Inc. (SILO).